
Precision BioSciences Presents Preclinical Data on PBGENE-DMD for DMD at MDA 2025
Precision BioSciences Presents Promising Preclinical Data for PBGENE-DMD in Duchenne Muscular Dystrophy at 2025 MDA Conference Introduction to PBGENE-DMD and the DMD Challenge Precision BioSciences, Inc., a clinical-stage gene editing company, has announced the presentation of promising preclinical data for…